In our study using a nationwide registry in an area with intermediate tuberculosis burden, 23 patients restarted TNF inhibitors after initiating anti-tuberculosis treatment without aggravation of the tuberculosis, delay of the treatment or tuberculosis-related deaths. The gene discussed is TNF; the disease is tuberculosis.